Abstract
Clinical ThyroidologyVol. 27, No. 2 SummariesRadioiodine Ablative Doses Greater Than 54 mCi Improve Recurrence-Free Survival in Older Patients With Differentiated Thyroid CancerJerome M. HershmanJerome M. HershmanSearch for more papers by this authorPublished Online:16 Feb 2015https://doi.org/10.1089/ct.2015;27.43-44AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Radioiodine Ablative Doses Greater Than 54 mCi Improve Recurrence-Free Survival in Older Patients With Differentiated Thyroid Cancer." Clinical Thyroidology, 27(2), pp. 43–44FiguresReferencesRelatedDetails Volume 27Issue 2Feb 2015 InformationCopyright 2015 American Thyroid Association, Inc.To cite this article:Jerome M. Hershman.Radioiodine Ablative Doses Greater Than 54 mCi Improve Recurrence-Free Survival in Older Patients With Differentiated Thyroid Cancer.Clinical Thyroidology.Feb 2015.43-44.http://doi.org/10.1089/ct.2015;27.43-44Published in Volume: 27 Issue 2: February 16, 2015PDF download
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
